92 results on '"Andreadou I"'
Search Results
2. Establishment of an in vivo murine model of immune checkPoint inhibitors cardiotoxicity: emerging role of vascular permeability in pembrolizumab-induced cardiotoxicity
3. Cardiotoxicity in light chain amyloidosis: Insights from the first murine model with intramyocardial injection of patient-derived amyloidogenic light chains
4. Olive extract enriched with hydroxytyrosol improves cardiac and vascular function in patients with stable coronary artery disease: a double-blind, placebo-controlled trial
5. Empagliflozin restores the deregulated cardiac endothelial cell transcriptome in vivo upon myocardial ischemia reperfusion injury and reduces the infiltration of immune cells
6. Cardioprotection by selective SGLT2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
7. SARS-CoV-2 is associated withabnormal biomarkers of oxidative stress,and endothelial function linked with cardiovascular dysfunction four months after the infection
8. Understanding the molecular mosaic of cardiotoxicity of light chains in plasma cell dyscrasias and cardiac light chain amyloidosis with the use of patient derived full-length light chains
9. Empagliflozin rescues primary murine cardiac fibroblasts, but not cardiomyocytes, from hypoxia-reoxygenation injury through STAT3-mediated cascades
10. Impaired endothelial glycocalyx, vascular dysfunction and myocardial deformation four months after COVID-19 infection are partially improved at twelve months
11. Endothelial dysfunction due to decreased nitric oxide bioavailability in dysglycaemic subjects and first-degree relatives of type 2 diabetic patients
12. 33P Immune checkpoint inhibitor-induced cardiotoxicity is driven through inflammation, autophagy and stress
13. Vascular conditioning prevents adverse left ventricular remodelling after acute myocardial infarction: a randomised remote conditioning study
14. Association of COVID-19 with impaired endothelial glycocalyx, coronary flow and longitudinal strain four months after infection
15. Association of COVID-19 with impaired endothelial glycocalyx, vascular function and myocardial efficiency four months after infection
16. Mineralocorticoid receptor signaling is implicated in carfilzomib-induced increase in blood pressure
17. Acute administration of the olive constituent, oleuropein, combined with post-conditioning mechanism exerts cardioprotective effects by modulating oxidative defense
18. Comparative study on the cardioprotective effects against ischemia/reperfusion injury of the selective SGLT2 inhibitors, empagliflozin, dapagliflozin and ertugliflozin in non-diabetic mice
19. Comparative study of the bioactive compounds of olive products on cardioprotection from ischemia-reperfusion injury in mice with metabolic syndrome
20. The midterm differential effects of heat-not-burn and conventional cigarettes on coronary flow, vascular function and oxidative stress are independent of nicotine levels
21. First-degree relatives of type-2 diabetic patients and dysglycaemic patients have impaired endothelial function due to decreased bioavailability of nitric oxide
22. The effect of one year treatment with GLP1-RA, SGLT2i and their combination on plasma levels of oxidative and antioxidative biomarkers
23. List of Contributors
24. Effects of glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors on myocardial deformation and work index in type 2 diabetes: 1 year follow up
25. Effects of heat-not-burn compared to combustible cigarettes on coronary flow, myocardial work index and vascular function
26. Hydrolytic activity of mitochondrial F1Fo ATP synthase as a target for myocardial ischemia: discovery and in vitro evaluation of novel inhibitors
27. Effects of electronic cigarette on platelet and vascular function after one month of use
28. Effects of glucagon like peptide-1 receptor agonists, sodium-glucose cotransporter-2 inhibitors and their combination on vascular function and myocardial work index in patient with type-2 diabetes
29. Al amyloidosis with cardiac involvement: cardiotoxicity of aggregation prone peptides deriving from variable domains of immunoglobulin light chains
30. Differential effects of heat-not-burn and conventional cigarettes on coronary flow, myocardial and vascular function, platelet activation and oxidative stress
31. Glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors improve myocardial deformation and work index in type-2 diabetes after 12-month treatment
32. Inhibition of interleukin-6 by tocilizumab improves endothelial glycocalyx and myocardial work index in patients with rheumatoid arthritis
33. Beta-amyloid and mitochondrial-derived peptide-c are additive predictors of adverse outcome to high-on-treatment platelet reactivity in type 2 diabetics with revascularized coronary artery disease
34. Investigating the impact of aging and hyperlipidaemia on metformin cardioprotection against carfilzomib-induced cardiotoxicity in vivo
35. Sodium-glucose cotransporter-2 inhibitors and their combination with glucagon like peptide-1 receptor agonists improve endothelial glycocalyx and arterial stiffness in type-2 diabetes
36. P357 Remote ischemic post-conditioning may prevent cardiac remodeling within two years of STEMI by cardioprotective microRNA upregulation
37. P1588 micro rna expression profiling may predict cardiac remodeling after stemi
38. The natural product Oleuropein shows enhanced anticancer and cardioprotective activity when co-administered in vivo with Doxorubicin
39. P4435Effects of interleukin 6 inhibitor tocilizumab on endothelial glycocalyx, vascular and myocardial function compared to prednisolone
40. P3488Mechanistic insight on the cardioprotective effect of levosimendan against doxorubicin induced cardiomyopathy: Pivotal role of PKA signaling
41. P4461Chronic administration of Empagliflozin induces cardioprotection in vivo in absence of diabetes mellitus
42. P5741Impaired arterial elastic properties and endothelial glycocalyx in patients with embolic stroke of undetermined source
43. P4445Effects of interleukin 17A inhibition on myocardial deformation and vascular function in psoriasis:one year follow-up
44. P2589Platelets serve as carriers of cardioprotective factors after remote ischemic conditioning in humans
45. P4787Investigating the molecular mechanisms of carfilzomib-induced cardiotoxicity and the emerging role of metformin as a prophylactic therapy
46. P3204The role of microRNA expression in remote ischemic conditioning improvement of aortic elastic properties and endothelial glycocalyx integrity in acute myocardial infarction
47. P2837Levosimendan abrogates early stage and progressive arrhythmogenic right ventricular cardiomyopathy in desmin null mice
48. P5426Effects of inhibition of interleukin 1 and 6 activity on myocardial and vascular function compared with prednisolone in patients with rheumatoid arthritis
49. P4754Pivotal role of the region-specific phosphorylation of GSK3beta in cardioprotection in anesthetized mice
50. 4324Effects of the glucagon like peptide-1 receptor agonist on arterial stiffness, LV myocardial deformation and oxidative stress in newly diagnosed type 2 diabetes after 6-month treatment
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.